Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI [Phase 2]
Phase 2 clinical trial update investigating preoperative staging and dose-escalated radiotherapy for prostate cancer using PET and MRI.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Motorised Probe Holder Assisting Prostate Biopsies [NA]
Clinical trial update on a motorised probe holder to assist prostate biopsies in prostate cancer; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods [NA]
Update on a terminated clinical trial evaluating multiparametric MRI methods for localization and characterization of prostate cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients [Phase 1]
Phase 1 study assessing safety, biodistribution, radiation dosimetry, and pharmacokinetics of BAY88-8223 in Japanese patients with prostate …
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer [Phase 3]
A Phase 3 trial evaluating OGX-011 in combination with docetaxel and prednisone for men with prostate cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer [Phase 2, Phase 3]
A Phase 2/3 trial comparing 0.5 mg daily dutasteride to placebo in men receiving androgen deprivation therapy for prostate cancer has comple…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer [Phase 4]
Phase 4 open-label crossover study in men with advanced prostate cancer evaluating whether switching among Lupron, Eligard, and Zoladex main…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Safety Study of Human MUC-1 (Mucin-1) Adenoviral Vector Vaccine for Immunotherapy of Epithelial Cancers [Phase 1]
This entry covers a Phase 1 safety study of a human MUC-1 adenoviral vector vaccine designed for immunotherapy of epithelial cancers. The st…
-
CLINICAL_TRIALS trial_result · 2016-10-12Clinical Trial Update: Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer [Phase 3]
Phase 3 trial in second-line prostate cancer comparing cabazitaxel/prednisone alone to with custirsen has completed. The document does not i…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer [Phase 3]
A Phase 3 trial compares cabazitaxel at 20 mg/m² vs 25 mg/m² with prednisone in metastatic castration-resistant prostate cancer; results hav…
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer [NA]
The trial comparing whole-body bone scan versus 18F-choline PET/CT in prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer [Phase 2]
Phase 2 trial assessing a combined antiinflammatory and antiangiogenic therapy in patients with hormone-refractory prostate cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluated adding the IGF-1R inhibitor cixutumumab to standard androgen deprivation therapy with or without bicalutamide in n…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating an NY-ESO-1 vaccine therapy with or without sirolimus in patients whose tumors express NY-ESO-1.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Hypofractionated Intensity Modulated Radiation Therapy Plus Hormonal Therapy in Patients With High Risk Prostate Cancer [NA]
This clinical trial evaluating hypofractionated intensity-modulated radiation therapy plus hormonal therapy in high-risk prostate cancer has…
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy [Phase 3]
Phase 3 trial evaluating whether radiotherapy followed by endocrine therapy improves outcomes compared with endocrine therapy alone for PSA …
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating an autologous dendritic cell vaccine expressing the MUC1 antigen in prostate cancer; the study status is co…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Energy Balance for Prostate Cancer Survivorship [NA]
A completed clinical trial update on energy balance for prostate cancer survivorship led by Jill Hamilton-Reeves, PhD RD LD.
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer [Phase 1]
Phase 1 trial evaluating the ProxiScan transrectal scintigraphic detector for detection of primary prostate cancer. The study status is COMP…
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Evaluation of the Accuracy of the Elastic Fusion MRI-ultrasound Obtained in Vivo by the Koelis™ System
Clinical trial update evaluating the accuracy of the Koelis elastic fusion MRI-ultrasound system in vivo for prostate cancer imaging. The st…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy [Phase 2]
Phase 2 trial assessing androgen deprivation therapy with or without Bevacizumab for PSA recurrence of prostate cancer after definitive loca…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: For Cause Prostate Biopsy in REDUCE Population Trial
An update on the REDUCE trial focusing on for-cause prostate biopsies within the study population; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer [Phase 3]
A Phase 3 trial of an immunotherapy for advanced prostate cancer completed, with results posted in August 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy [NA]
A completed clinical trial comparing totally intravenous anesthesia and inhalation anesthesia during robot-assisted laparoscopic radical pro…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation
An observational study evaluating how well Eligard (leuprolide acetate) works and its tolerability in patients with advanced prostate cancer…